Canada applies counter-tariffs to a list of American goods from 8 September 2026, and in cosmetics the list names exactly five tariff lines, all at 50%: perfume, lip make-up, eye make-up, manicure and pedicure preparations, and the residual hair line. Face and skin care preparations are not on it. Neither is shampoo. That single fact reverses the reading now circulating in the Korean trade press, because the categories the measure opens are not the categories Korean brands se

Sulwhasoo is marking sixty years of ginseng research this month, and the product the anniversary is attached to — the Concentrated Ginseng Rejuvenating Cream — went on sale in 2000. Both facts come from Amorepacific and both are true, because the sixty years belong to a research programme rather than to a jar. That distinction is the only part of this anniversary a young brand can actually copy, and it is worth more than it first looks.

Indonesia’s transition period for mandatory halal cosmetic certification ends October 17, 2026, with enforcement starting October 18 under Government Regulation No. 42 of 2024. The rule applies equally to local and foreign brands. Compliance requires factory changes—separating lines, tracking ingredients, and appointing a supervisor. However, foreign exporters face heavy administrative friction: brands must file through local importers.

Foreign shoppers made 11.01 million purchases in CJ Olive Young's Korean stores between January and August 2026, spending more than 1 trillion won. None of it counts as an export, and most brands on those shelves have no idea who those customers were. This is what the number actually means for anyone building a Korean beauty brand for overseas markets.

Nothing in an American refusal notice for a Korean cosmetic is about chemistry. In FY2025, 69 per cent of Korea's US FDA cosmetics import refusals came down to labelling, and the same month that Korea's own regulator published its August enforcement record, five of its nine actions were for advertising liable to be mistaken for medicine. The compliance failure that actually stops Korean cosmetics, in both jurisdictions, is the sentence on the label — not the formula in the ja

Everything written in English about K-beauty recently centers on going upmarket—expanding Korean assortments into American prestige and mass retail doors. Meanwhile, the domestic beauty category inside Korea that surged roughly 144 percent in 2024 and another 70 percent in 2025 sells nothing above 5,000 won (USD 3.60). A hard price ceiling is not a discount. It is a product development brief—and what it strips out is precisely the apparatus Korean brands rely on to export.

On 25 August 2026 the US sun care brand Vacation named Nelson Miranda its chief executive, the first outside CEO in the brand's five-year life. All three founders stayed, in narrowed creative roles. The useful detail is not the hire but the line the founders drew through their own business before making it — and what fell on the far side of that line was not operations. It was marketing.

Target Beauty Studio opens on 10 September in more than 600 US stores, replacing the Ulta Beauty at Target shop-in-shops that closed on 16 August. Target's announcement names six Korean brands under two explicit K-Beauty headings — and names a seventh Korean brand, Eqqualberry, under curated skincare instead. For a Korean brand, which of those two labels you are given is a bigger commercial fact than the listing itself.

TikTok Korea and the consulting firm Kearney published a study on 26 August 2026 estimating that K-culture on TikTok will be worth USD 30.4 billion by 2030, with K-beauty the largest of six sectors on direct economic impact at USD 2.45 billion. The headline is already circulating through the Korean beauty industry as though it were a market size. It is not one — it is a sum that adds consumer spending outside Korea to a modelled multiplier inside Korea.

A KOSDAQ-listed maker of secondary-battery and display equipment has bought a cosmetics filling-and-packaging automation company for USD 17.7 million, in a deal brokered by a Korean state credit-guarantee fund. It is a small transaction, and it describes where the K-beauty industry's constraint actually sits far better than the export figures do. The thing that stops an indie brand scaling into a new market is almost never the formulation. It is the filling line.

LG Household & Health Care agreed to sell Avon North America to Regent affiliate Stratford Worldwide for $6M—a sharp drop from the $330M invested since 2019 ($125M purchase + $205.5M loan). The low price doesn't mark the death of direct selling, as model expansion elsewhere shows. Instead, it reveals that a brand name and its underlying representative seller network are separate assets, with real value lying in the distribution machine itself.

Korea's National Assembly passed the Act on the Fostering and Support of the Cosmetics Industry on 20 August 2026. The only genuinely new instrument in it — certification as an "innovative cosmetics company" — has its qualifying thresholds left entirely to presidential decree. That means the law that decides who benefits will be written over the next twelve months, not last week, and if it is written as an R&D-spending gate it will certify the manufacturers and miss the expor

Estée Lauder wrote USD 375 million off Dr.Jart+ in fiscal 2025, then ran a sale process for the brand, took bids, and decided in July 2026 to keep it and shrink the team instead. The company's fiscal 2026 results, published on 19 August 2026, name Dr.Jart+ in exactly two places. This is the clearest public record of what happens to a Korean brand after the exit everyone treats as the finish line.

The Korean Intellectual Property Office is registering a K-Brand certification mark in 70 export countries and holding the rights itself. That choice of legal instrument is the argument: a certification mark exists precisely because the thing being protected belongs to a whole class of producers rather than to any one of them. This piece sets out why "K-beauty" is a country-of-origin commons rather than brand equity, and what a Korean exporter actually owns once the adjective

Amorepacific's Mamonde began selling exclusively on Nykaa this month at a price below most of the Korean brands already on the platform. Two of those brands, Laneige and Cosrx, belong to Amorepacific. This piece sets out why a single dominant platform is the one place a multi-brand group cannot hide its own price ladder, and what that costs the brand placed at the bottom of it.

On 18 August, CVC Capital Partners subscribed KRW 300bn of new Silicon2 shares at a premium, taking 9.23% of a company that owns no beauty brand at all. Six months earlier, Goodai Global had bought the distributor Hansung USA to take its North American supply chain in-house. This piece reads the two deals as the same structural problem solved from opposite ends, and sets out what the aggregator model actually leaves a Korean brand holding.

Olive Young placing 19 Korean beauty brands inside Sephora US marks a shift from exporting products to exporting retail judgment. But distribution isn't narrative ownership—brands must build standalone equity before the bi-annual shelf reset. To turn temporary shelf presence into long-term global growth, Korean brands must negotiate for customer data, brand storytelling space, and a clear path toward direct retail representation.

The rise of K-Beauty is built on supply chain supremacy and industrial speed. Moving beyond viral trends requires direct access to South Korea’s manufacturing backbone, regulatory compliance, and cross-border logistics. Partner with parallel37.kr to navigate complex global expansion, optimize product formulations, and turn real-time market intelligence into sustainable competitive advantage.

East African nilotica shea is held back not by capacity, but because "shea butter" is a settled category defined by affordable West African shea. While a emerging Korean refining hub solves procurement mechanics for local brands, it threatens to capture the high-margin refining and formulation steps already performed in Uganda. To avoid capping Uganda's potential, the hub must be built as a transitional stage with clear progression terms.

Saudi Arabia's FDA will prohibit cosmetic products in syringe form starting 1 January 2027. Ampoules and vials remain permitted conditionally if they feature four specific Arabic and English warnings on packaging. Brands have until 31 December 2026 to recall affected stock and update compliance. This regulation treats packaging format as an implied claim, requiring K-beauty brands to audit both bilingual labelling and marketing assets to avoid market restrictions.